182 related articles for article (PubMed ID: 25280518)
1. Triptolide induces apoptosis of gastric cancer cells via inhibiting the overexpression of MDM2.
Wang BY; Cao J; Chen JW; Liu QY
Med Oncol; 2014 Nov; 31(11):270. PubMed ID: 25280518
[TBL] [Abstract][Full Text] [Related]
2. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
Huang M; Zhang H; Liu T; Tian D; Gu L; Zhou M
Mol Cancer Ther; 2013 Feb; 12(2):184-94. PubMed ID: 23243057
[TBL] [Abstract][Full Text] [Related]
3. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
[TBL] [Abstract][Full Text] [Related]
4. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
5. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
Kiviharju TM; Lecane PS; Sellers RG; Peehl DM
Clin Cancer Res; 2002 Aug; 8(8):2666-74. PubMed ID: 12171899
[TBL] [Abstract][Full Text] [Related]
7. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
8. MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status.
Li W; Liu Y; Li XX; Yu Y; Wu JJ; Wang Q; Huo H; Wang LM; Yang L
Planta Med; 2011 Jan; 77(1):27-31. PubMed ID: 20607649
[TBL] [Abstract][Full Text] [Related]
9. Triptolide interrupts rRNA synthesis and induces the RPL23‑MDM2‑p53 pathway to repress lung cancer cells.
Wang J; Zhang ZQ; Li FQ; Chen JN; Gong X; Cao BB; Wang W
Oncol Rep; 2020 Jun; 43(6):1863-1874. PubMed ID: 32236588
[TBL] [Abstract][Full Text] [Related]
10. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
11. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
12. Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity.
Krosch TC; Sangwan V; Banerjee S; Mujumdar N; Dudeja V; Saluja AK; Vickers SM
Am J Surg; 2013 Apr; 205(4):387-96. PubMed ID: 23428154
[TBL] [Abstract][Full Text] [Related]
13. Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation.
Xiaowen H; Yi S
Mol Biol Rep; 2012 Sep; 39(9):8763-70. PubMed ID: 22707197
[TBL] [Abstract][Full Text] [Related]
14. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
[TBL] [Abstract][Full Text] [Related]
15. Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B.
Wen L; Chen Y; Zeng LL; Zhao F; Li R; Liu Y; Zhang C
Acta Pharmacol Sin; 2012 Jan; 33(1):109-19. PubMed ID: 22120968
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance.
Li M; Zhang X; Zhou WJ; Chen YH; Liu H; Liu L; Yang CM; Qan WB
Acta Pharmacol Sin; 2013 Dec; 34(12):1545-53. PubMed ID: 24241349
[TBL] [Abstract][Full Text] [Related]
17. Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
Kim ST; Kim SY; Lee J; Kim K; Park SH; Park YS; Lim HY; Kang WK; Park JO
BMC Cancer; 2018 Nov; 18(1):1103. PubMed ID: 30419860
[TBL] [Abstract][Full Text] [Related]
18. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
19. Role of Hsp-70 in triptolide-mediated cell death of neuroblastoma.
Antonoff MB; Chugh R; Skube SJ; Dudeja V; Borja-Cacho D; Clawson KA; Vickers SM; Saluja AK
J Surg Res; 2010 Sep; 163(1):72-8. PubMed ID: 20638672
[TBL] [Abstract][Full Text] [Related]
20. Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway.
Cui J; Li X; Wang S; Su Y; Chen X; Cao L; Zhi X; Qiu Z; Wang Y; Jiang H; Huang B; Ji F; Su J
J Cell Mol Med; 2020 Jun; 24(11):6149-6161. PubMed ID: 32347017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
